During the past decade, BTC of New Bedford conducted 16 clinical trials. In the 10-year time frame, 16 clinical trials started and 12 clinical trials were completed, i.e. on average, 75% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 12 clinical trials were completed. i.e. 200% of trials that started reached the finish line.

Out of the total clinical trials conducted in "BTC of New Bedford" #1 sponsor was "Allergan" with 4 trials, followed by "Janssen Research & Development, LLC" with 2 trials sponsored, "Naurex, Inc, an affiliate of Allergan plc" with 2 trials sponsored, "Satsuma Pharmaceuticals, Inc." with 2 trials sponsored and "AOBiome LLC" with 2 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "BTC of New Bedford" #1 collaborator was "Veristat, Inc." with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "BTC of New Bedford" are "Depressive Disorder, Major" (4 trials), "Migraine" (3 trials), "Episodic Migraine" (2 trials), "Migraine With Aura" (2 trials) and "Migraine Without Aura" (2 trials). Many other conditions were trialed in "BTC of New Bedford" in a lesser frequency.

Most popular intervention types in "BTC of New Bedford" are "Drug" (15 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (6 trials), "Atogepant" (2 trials), "Dihydroergotamine" (2 trials), "Placebo-matching Ubrogepant" (2 trials) and "Quetiapine XR" (2 trials). Other intervention names were less common.

The vast majority of trials in "BTC of New Bedford" are 16 trials for "All" genders.

Currently, there are NaN active trials in "BTC of New Bedford". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 14 completed trials in BTC of New Bedford, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in BTC of New Bedford, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 12 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".